OneMedNet (ONMD) CMO invests $100K, buying 172,414 new common shares

Rhea-AI Filing Summary

OneMedNet Corp Chief Medical Officer Jeffrey Yu made a substantial open-market purchase of company stock. On June 16, 2026, he bought 172,414 shares of common stock at $0.58 per share under a subscription agreement for a $100,000 investment.

Following this purchase, Yu directly holds 8,621,680 shares of OneMedNet common stock. The filing also reports 1,311,970 shares held indirectly in a trust for his children with an independent trustee, for which he has no investment control and disclaims beneficial ownership.

Insights

Insider trading analyst

CMO makes a $100,000 open-market buy, increasing direct holdings.

The filing shows Jeffrey Yu, Chief Medical Officer and a more than 10% owner, entered a subscription agreement on June 16, 2026 for a $100,000 investment, buying 172,414 common shares at $0.58 per share.

After this transaction, his direct ownership rises to 8,621,680 shares, while an additional 1,311,970 shares sit in a children’s trust with an independent trustee. The filing states he has no investment control over those trust shares and expressly disclaims beneficial ownership.

This is a clear open-market purchase, not an option exercise or tax event, which often signals insider conviction. However, the overall impact depends on the company’s total share count, which is not provided in this excerpt.

Insider Trade Summary

Net Buyer: 172,414 shares ($100,000)

Net Buy 2 txns

Insider Yu Jeffrey

Role Chief Medical Officer

Bought 172,414 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	172,414	$0.58	$100K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,621,680 shares (Direct, null); Common Stock — 1,311,970 shares (Indirect, By trust for children)

Footnotes (1)

1. On June 16, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

Key Figures

Shares purchased: 172,414 shares Purchase price: $0.58 per share Investment amount: $100,000 +3 more

6 metrics

Shares purchased 172,414 shares Common stock bought June 16, 2026

Purchase price $0.58 per share Price for 172,414 common shares

Investment amount $100,000 Subscription agreement with issuer on June 16, 2026

Direct holdings after transaction 8,621,680 shares Common stock directly owned by Jeffrey Yu

Trust-held shares 1,311,970 shares Held by trust for children; Yu disclaims beneficial ownership

Buy transactions 1 transaction Net-buy direction with 172,414 shares

Key Terms

subscription agreement, beneficial ownership, independent trustee, Section 16, +1 more

5 terms

subscription agreement financial

"the issuer entered into a subscription agreement with the reporting person for a $100,000 investment"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

beneficial ownership regulatory

"The reporting person disclaims beneficial ownership of these shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

independent trustee financial

"The shares are held by trust with an independent trustee"

Section 16 regulatory

"for purposes of Section 16 or for any other purpose"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

more than 10% owner regulatory

"is_ten_percent_owner": 1"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yu Jeffrey

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD,

SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		P(1)		172,414	A	$0.58	8,621,680	D
Common Stock								1,311,970	I	By trust for children(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On June 16, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

2. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

	/s/ Robert Golden, Attorney-in-Fact	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did OneMedNet (ONMD) report for Jeffrey Yu?

Jeffrey Yu, OneMedNet’s Chief Medical Officer, reported buying 172,414 common shares in an open-market purchase at $0.58 per share, tied to a $100,000 subscription agreement investment dated June 16, 2026.

How many OneMedNet (ONMD) shares does Jeffrey Yu hold after this Form 4?

After the reported purchase, Jeffrey Yu directly holds 8,621,680 shares of OneMedNet common stock. The filing also lists 1,311,970 shares in a children’s trust, where he has no investment control and disclaims beneficial ownership.

What price did Jeffrey Yu pay for OneMedNet (ONMD) shares?

Jeffrey Yu paid $0.58 per share for 172,414 shares of OneMedNet common stock. The transaction comes through a $100,000 subscription agreement investment dated June 16, 2026, indicating a negotiated open-market or private purchase price.

What is the $100,000 subscription agreement mentioned for OneMedNet (ONMD)?

On June 16, 2026, OneMedNet entered into a subscription agreement with Jeffrey Yu for a $100,000 investment. Under this agreement, he acquired 172,414 common shares at $0.58 per share, increasing his direct ownership stake.

How are the trust-held OneMedNet (ONMD) shares treated in Jeffrey Yu’s Form 4?

The Form 4 shows 1,311,970 shares held by a trust for Yu’s children with an independent trustee. The filing states he has no investment control over these shares and explicitly disclaims beneficial ownership for Section 16 and other purposes.